Top No­var­tis man­u­fac­tur­ing ex­ec jumps ship, takes charge of in­dus­tri­al­iz­ing Mod­er­na’s mR­NA tech

A lit­tle over a year ago No­var­tis’ CEO Joe Jimenez put Juan An­dres in charge of a move to slice a bil­lion dol­lars out of the glob­al man­u­fac­tur­ing bud­get through a cen­tral­ized ser­vices project. It was a clas­sic No­var­tis move, win­kling out costs in its nev­er-end­ing stream­lin­ing ef­fort that had al­ready seen it re­vamp man­u­fac­tur­ing, with 25 fa­cil­i­ties re­struc­tured or di­vest­ed over a 6-year pe­ri­od.

Now An­dres is tak­ing his Big Man­u­fac­tur­ing skills gained in Big Phar­ma — in­clud­ing the pi­o­neer­ing work done on CAR-T man­u­fac­tur­ing — and putting it to work for Mod­er­na as the biotech preps its own cen­tral man­u­fac­tur­ing site for its mR­NA plat­form. Of­fi­cial­ly, he’s hand­ing in his ti­tle as glob­al head tech­ni­cal op­er­a­tions (man­u­fac­tur­ing and sup­ply) at No­var­tis for se­nior vice pres­i­dent of
late stage tech­ni­cal de­vel­op­ment and man­u­fac­tur­ing (be­yond hu­man proof of con­cept) for Mod­er­na.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER